Stericycle (SRCL) Reports In-Line Q2 EPS, Revenue Light
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Imperial Capital Downgrades Stericycle (SRCL) to Underperform
July 29, 2016 10:26 AM EDTImperial Capital downgraded Stericycle (NASDAQ: SRCL) from In-Line to Underperform with a price target of $93.50 (from $100.00).
Analyst Scott Levine commented, "We are lowering our rating on SRCL shares to Underperform from In-Line, and are lowering our one-year price target to $93.50 from $100. Our... More



